We report a patient with rheumatoid arthritis (RA) who developed leukoencephalopathy while being treated with low-dose methotrexate (MTX). She suddenly developed loss of recent memory and left homonymous hemianopsia ascribable to the bilateral but right-predominant occipitotemporal lesions. Intravenous administration of dexamethasone and cessation of MTX quickly relieved her clinical symptoms. Low-dose MTXinduced leukoencephalopathy is a rare complication in RA, but is important with regard to the possibility of serious neurological sequellae. © 2011 The Japanese Society of Internal Medicine.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Matsuda, M., Kishida, D., Kinoshita, T., Hineno, A., Shimojima, Y., Fukushima, K., & Ikeda, S. I. (2011). Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis. Internal Medicine, 50(19), 2219–2222. https://doi.org/10.2169/internalmedicine.50.5552